Dossier
Chinese lung cancer therapy
Coverage of Chinese lung cancer therapy in the Nexus archive.
- STAT+: A turning point for pancreatic cancer patients
The article highlights recent advancements in pancreatic cancer treatment, including detailed results from daraxonrasib trials, and a Chinese lung cancer therapy exceeding expectations. It also discusses regulatory debates over a long-standing peptide used by biohackers.